Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Scatter Factor Receptor (c-Met) as Possible Prognostic Factor in Patients with Oral Squamous Cell Carcinoma

L. LO MUZIO, R. LEONARDI, M.D. MIGNOGNA, G. PANNONE, C. RUBINI, T. PIERAMICI, L. TREVISIOL, F. FERRARI, R. SERPICO, N. TESTA, G. DE ROSA and S. STAIBANO
Anticancer Research March 2004, 24 (2C) 1063-1070;
L. LO MUZIO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. LEONARDI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.D. MIGNOGNA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. PANNONE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. RUBINI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. PIERAMICI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. TREVISIOL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. FERRARI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. SERPICO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. TESTA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. DE ROSA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. STAIBANO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

This report was performed to study the biological role of c-Met in oral tumorigenesis by analyzing its expression in relation to clinicopathological features. Seventy-three cases of oral squamous cell carcinoma and 10 of normal mucosa were analysed for c-Met expression by immunohistochemistry. Normal oral squamous epithelium showed absent or low membranous positivity in the intermediate (malpighian - spinous) layer. Fifty-seven cases (78%) of carcinoma showed immunopositivity, with a prevalently membranous positivity and scattered areas also showing a cytoplasmic localization. Sixteen cases of carcinoma (22%) showed no positivity for c-Met. Among positive tumours, well-differentiated areas showed low or absent cytoplasmic positivity, while low-differentiated areas showed both membranous and cytoplasmic positivity. There was no statistically significant correlation between c-Met expression and sex, recurrence, staging or grading. The frequency of lymph node metastases was higher in c-Met-positive tumours (17/57, 29%) than in c-Met-negative ones (4/16, 25%). When analysed for prognostic significance, patients with negative/reduced c-Met expression had better survival rates than patients with high expression. The difference between survival rates was statistically significant (p<0.05). These data suggest that c-Met expression may be useful to identify cases of oral squamous cell carcinoma with a more aggressive and invasive phenotype.

Footnotes

    • Received October 22, 2003.
    • Accepted February 18, 2004.
  • Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 24, Issue 2C
March-April 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Scatter Factor Receptor (c-Met) as Possible Prognostic Factor in Patients with Oral Squamous Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Scatter Factor Receptor (c-Met) as Possible Prognostic Factor in Patients with Oral Squamous Cell Carcinoma
L. LO MUZIO, R. LEONARDI, M.D. MIGNOGNA, G. PANNONE, C. RUBINI, T. PIERAMICI, L. TREVISIOL, F. FERRARI, R. SERPICO, N. TESTA, G. DE ROSA, S. STAIBANO
Anticancer Research Mar 2004, 24 (2C) 1063-1070;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Scatter Factor Receptor (c-Met) as Possible Prognostic Factor in Patients with Oral Squamous Cell Carcinoma
L. LO MUZIO, R. LEONARDI, M.D. MIGNOGNA, G. PANNONE, C. RUBINI, T. PIERAMICI, L. TREVISIOL, F. FERRARI, R. SERPICO, N. TESTA, G. DE ROSA, S. STAIBANO
Anticancer Research Mar 2004, 24 (2C) 1063-1070;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma
  • Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions
  • Google Scholar

More in this TOC Section

  • Relationship Between Histopathological Growth Patterns and Indocyanine Green Fluorescence in Colorectal Liver Metastases
  • The Role of MRI in the Preoperative Staging of Rectal Cancer: Ten-year Experience from a Single Tertiary Center
  • Impact of Postoperative Prognostic Nutritional Index on Post-gastrectomy Outcomes in Older Adults With Gastric Cancer
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire